INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (155009,661,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155027,664,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155029,664,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155031,664,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155049,666,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155051,666,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'789ccd564b72dc3610bd4a2f67aaa4b17eb6a7b253a294a285655734ce1e247b4844244003e0c8dce50eb9470e91a3e424790d901c6a2455594916d971068deed7af5f77e3eae3dde5f58f74797b4597571f6e6e6fee363f5f6e6e3eded2a662bad3a6ac993e7bc6e9d5f12fca0455f29f7fd04eabda93724c5beb489be0d48e8ded3c75b0b5a6ee577463b69c076d8d27bba500778e7dab9d0ad6f5841b7920650af2761b2868ef3bf62bfaa48266133c3db02e2bc4a78b13ba2f69b15e539df925215e631d7f47676f4fa82929587a7b12bf78c770fc8e2adbb9673dd5ec3d802873e0537c253f70f3e6be7c53a81e49117fe9545df754e89d2eb8a0c27a46d681de1d8bf9fa388692f4d9ed40c8733997ca0767c5c4076d541d532ed9e880abf863a4c2d3429bbcee0a011a2a44a25c81cc82b29e6e19f4b0d38a4a6bac739565c58270cb8d4256cbd7f0f6efd9fa2f788ae404c72a34082b6ce595b346e7f4889648d78c3d3d117c445b87c072398321d8b1b52d753e509cd7daa41f6deb94f672d793e11c59c1fb8aeec05ccd6e001bf34cb43bce6d03509289caec8ec9037e5d90b108c5a2f062453f81a5e9f660301cc69ef0a1cb32eb8cf0ee856b9e618f044c16f39cc08a536d4f0d98cd04cb974ebbd1a5b8411e0fccf7e2228c565356c2766e0da8ea78c68029dee0fa214b5b5bd7f6e1b86b1f396f70bd42f1b6b0a5e856900d6a16682bfaec38544ea365a5f8518054202082dfaee60a5dd165d1d5d0d45fbffd4e9b073bb0055fa306555e894e9499c421a76b71757a364a7333a96462a5c53f60456f67b92309fe1a52dd703052f782d86cd3d6a061ead50136034137e57744be13849e5a677d80b5242df2e25617bae89b6485d3da9a520433c8d5780de18cd5c4a599aa56f4831a7898a2d2830e088478be8518e0a975ba91b4c0ee5000dfb795aef524b70a33970ae5eeb79af193bfaa063d9232ca18458d5a6634a58c9431fbc807a44f56d061c80894874a040ae900a40e18f3fb60126f047594e48156c7349a8424cd39ef814615692f280220dd748da0dfca0848ea5ac5e592c42076529d56a0c6e1b76f87b1de25b83432075947cc621f774ed3f9bcab95a38325e46c17447d98290a6511395911b76a5a9debba8eb2ed27acc8dec4396141ba929bdfa75ec1950f18d5a68c751fc41ca70bb8291c6e89b24f310f11e1ece49bc6629abbe772e36254f8e289c4c15bd051e35118f3e40aa7db495911ccd0f173db89196d7e1d87cef280f6248057d03d0018c99e620c74dfb285fce07cb15f1dd294424324680db5f651f72dba09b652929297744c57d6e36b26a24cc92485f0af39369e35c93866fc697e9d549e5b97f6a6a58dcaf06239a7d5f435b84641fe3940a1eb594d089a3b6e83ceb9c17a3e04bb88b37a79007821519623b0e7b19c5fbc70f09e4e5f23b4718cbe1ca614edc5321f9cad6376fb7ba0e7f4db56ff41e847115e4cecb5eed783f719fdafe950bc008272e1697fa942a6165e6d69f3c5411680190f398076cc4924f3ce4b4e9e8ea5d818cf76fcffaa5716f199b39c6f5ac4951d311b0efb70fb79f364c85fc4d5fd7e2c7cc6bd0584b87d7523fb508534edd36b13065838f256f47dd306dbe0ef3cf220e536398bcf6cea3b8cbc62d8d9587ee21ef5b55950dac856bd9c23393d4904eeb7fee3259cb09b7e9fe2ecbd7d8dc2b5f0977150c71537b6ee05183401add9dce6b9963c2bae5b595c3b712f69e1a0736e04ae72a93eb67b97f2da8a1024bb7450d648dd757838709b9e1babbf01c61cd8fc','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155053,666,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155071,669,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155073,669,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155075,669,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155093,675,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'789ccd595d52234712be4abe4c048a603480191bcf3e31806789180b0289d8e75277a955a6bbaba7aa5a8cde7c073fed2df60c7b149f64bfccaa6eb584d801af23d62f044855f9f3e5977fc5e5cdf4fcd3159d4f2ee9fcf2e7ebc9f57476773ebbbe99d06c693c99da6b1708bf2dac2345b74be52a95ade9635b3ed0adca1e54a149d539c9e1a0eb5ce772b671ba51ced4057fecd44ad7b6f5a4f2ca7c0dadd39e6c5daec774693d4b703ab35585db2a185b476d72af6a7dd696ca113ec80d8e852d79a6fe051fe10a29a7d32dfcac448c2aa9695d637dafedba5ec4e3f8604161c98a7d639c0ad6ad0962219e9df176112818ef5bedc77033185d074f8fda144b76e9f4881e0a3a383ba372ee476c5b659dfe4027ef8fa82a28587a7f24bfe99586e0ef69695bb75752a9bd8721aade91c9b2a21c8879f750bccbd51abe91fed2aab25c038b9561a873f14e05fafe2d1f3f7b2baa24146ea54abfcfe742f9e02c1ff1c1304aec72a16b1370151f7450783a307556b6391b1a96d044996a3db4ced734d180473ba3a8b0b5756e69b5d26ce142570a5e8d5e83dbff8ed69f819380139c56014c0c8c56b674b636196dc112e9be41cff4001fd2c241315f9ee320d0b1a52d4c9620ce4a53c73f9ac629e3f9aea75a67f00ad2c7340572a576c958f133c2dea7073c5173bbd2e4617e99536da14a1307654c7f074afded74207d29a9e1433b9f5b5733ee9eb1d603db0580fec4d027a0e254b3a60ac8ced9962f2d1231896431f0e351eb071611ba53bd578c76666b40d5ea010275fe0ed777515ad8b2b48f6fdb664b7885eb4b046f81b3246225e3239bd9b431dd3b1d96ce04a9422404a41c0aa17c321e32744ce7795b8253bffffa1bcd1e6d420bb23a0eaa6cc93c51754f0efef68c451d9f74d49cf52ce95169f00950318b81ef70427f4d45115f74d03d43365b352560e8733599ad6141dbfb7748be650b3d2aacf501a7d969a6976e4c6ef275154fe1dbd2d6051326d1b5f606c4e9a2894b03568de942251c7aadf4680214419f6f4006486a9ca9d82da09b02e0d7cdd294a6a7db12859972e51e1646e34ffd5555c891e8d15c23a8c2658da4e492d2792f7880fa64d93a141936e571c904057560a4090a18f5ca585f67d461a407521dd5a8271227e730072a95ebd4c26090a9da8aad5f700988ec4248118f48063ec7d169d8d43cb6b0be86a67817c0b2e63aa88dd8cce79f34ac61a772b60dcc3ed41485b0309d2c935b558dc94c590a6dd7bdadf0be963a6101bae29b1f63aee0cacf28d57521714f6496ea026c72875bccec63d4436838397a51598c75f73bbe71da31fce009c5815b30c27121c6d0b9dc99a667961893327e78b647a66fda7e3cda813d12e0157027039e8c0b09ee89c6180032d0c1a6757052320c02d019d8ba16de634e0838cb2129f448504cc3c9864673c5b514d4ffa425f564c6e826a0dba1005259665dec9c96666a5e6a3aa671f7db874e3662f2c76d64c4f6d282cd99ea26984c57e8d0bbd61e48b91eed587cc05a469d61fb6df9eef4992f7ea0e3d770adaba4cfab29987e12697cb7fbf7f0ec9978bb9103b88e5f360dec98b2abf1d968bc4afc59923e08c76b921643415098c09fa41c4fd2b5c120179ba1d4b6009b31dbc168a77524cd3019a390a7954a72656f11f88ba5cf81cc3ea361fb85666e1c838ab151b729424f2affa9f4f31fbad0cff5dac20469c9a6e226a9426c017104c50174211e20fdba6a82e5fd22132438e075a659e6bccf44d4c13c35727444168f08db7950a6e6567b3eb4e4f82842b81905b63b73b4bd5e6f5c1c0ce19f10ba06f2e63aa8b74b5dd972cd868115609bcd6c9619f673a9cb86bbd98ac5b35bf8a275ae335c651c7fb4fc36fab5602ab077f18ba284ebaec534a19b3883606dbbbebbba9035f1a79b3bba9f5ed14f387fbecd4918783d602c169156e606e6c61d3cac314007d60088e26ec75e694c8074e041e04bf9acdf076fd10b61d7bd17a3f76fa2239e51b87d63b033651b9840718ca9b7b2c75bfed2d6983c7ebebdb99b9d4f661fe2c69b01461921c0d039a68db01eae949cedb5a547c97b89711cd41135e468473c9017f80b691bde1890f76c11a286b34626b7bcc522f1a841dd38d6a679032b73d4c3341cd3276b79eab20b645f5a683b79be2d0a1972443bcf8eb68dfbc166c5dea442572d340fee8afde79559340fb52a99ad16282206c64bed49186033c88decd1c389c5dbdc80c630a09bd5795ed37562800ce32b8588c8aafe147edfa32800e4aee570019492b79e4dcd393e7a43ecf78a4d49a91974053aa8e829f6a0942a7d0e37bc58e49ee31838ebeeacad68b6b9440727effffd2fba40c7035338332eb66ddf387f9b444d39bf11d47f489f606dd7fdfbc3fdf496908bdcbca47c579ffbd27f34fef10d4d235417cbd23ad48c97dd7cff862eb140384663fbc2716a15e9c2715c679f3f1f159ca4e3277be4730d3e1a9fe2a389ba285f74fd33622203e11df24cbbdf7ffda77f995f777ae14cc181c0e583d33f390cbdbad3bef9be28703d9a7d5f7841e47a6527a7af0df7c9133b5f0d68aff49b91ff2f4c7941e48f77aedfd41877e2dbc426974b2e303b0f14c3f787dda1dd740d817bd0a6a8c457bc64c3211b1197b39dd292142cb8fd73893771a576b25df17268b083e669afe3c2b2755f9c8ee7434460053f2addbd91f5b60d6be82fad38e8ed6640089627161ef876bc307ebbe8a6edb72f73a5cc8826f8ad4623df7788f2df006ffc471aa1f4b2fd5f15a5425d9ddb10ca3823612cf17baa3a3f56ac5429338330a0c0cce8b7dd94271f68cab537459de2cc7d2eb9d27416e0ef6fbe0803707c8919912765d4f76c599b2fadc85254ca4b029297c78325fae298d40813474e3f9e1288f98d148f3c80168cdeaca5c758da4d4221ee30ec5874758049df7d18f9eaf361f7e6ed639b8f597233b98ae90172386e37831e35a6792c71a0dba275b2c526daf6d72042edd0941fa6d293b2e460d28fd68c0129cec5f254d69a68c8a26c0da0616e606ec0accacfdeffcfc1e6af37d46423c0b39f69accced239bbc825286a4e5c9616342a36b1d621be3ff30e0479a3ea2196e33e5b22589e09b68f944dadca060d5f2add7e16ff4b834fcc6c78fa19e2a58deb28b8353a94a316ff9857cdc1503c85e738ac592566b9d43ba91f968fb11994b8f3caec832c17b23d78631e5c829319d29b83e94d0e257e336ca64d789d56348b1bde7d8c8fd5508dba73c5d27a7d24bd1301bec6207bf4464c1b734151ce80351987a7bbb151e768f94b694cd47fe8514670c1cb1cf1bd7c3b9456ad9cbb0dc18d9532457fb403e5af7c0ff82529be7d9bd25eb1667f855997b067781247bc86a14e3f4dcba323ebe2bc8ffd3940357b1af077e210c1c220e31e0cb2c668c48f57ef9d97e1d3894e744d9eafabad73d0cf04eeab8aa00cf315d9cdff356f7812637339addd0c72bac7ad3dbabc9f4ea92cea75835ef27d7b3f17f003c3d1b66','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155095,675,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155097,675,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'789cb556c972e33610fd953e5a55b2365bb3e4a658f60cabe4a52c3ba91c2112121183040d80b275cb35e77c437e6cbe24af416a21ed2476a672d14202afbb5fbf5ea6d7f3c997739a5c4d6932bd8caea2f9ddede42ebabea24956a85869ad72127942aed40b117b91d1d25852f9af32f6cae494890d2d24892453b9725e5a99d0624352f9545ac207453f91a97f5d9235a597ae4717788417db6b563058379c4a8c93148b9c61576a2d73c673da3cc12a0ee28129dd8107660d43c29396c2791a0ebefdf6c7704cc0654b6c9ab18476860113a901c94e22ae9595021e53a274c9508e9ee0368d03c46040d98ccc9204c5262be0e042cb7054e69e84032b2d8796a5dbf9331c03e364b075a3f79d7426521695b5ac7471a9c5c19d1e1d3929691add9e9f71e6e674717d4bf7f3f363bab1b21015b7c14ed4408876565df5dde9d11d12602502ce649ec0b6484aed3925622503196f0b43391af6c6b4a2a3213e0e2fb9906367125566e404c00b0df606e1f41eeee5b90e7943270c397a1be4f05f0125320569a9674a4d691d475f3b5e9bb2225f311f85950e59af20bcf142b7b8884dee5916c170b0b333bc7df566f2bae1656c2c8c16264f1c7b236a5f80d264b4df660e879b04f51b445429ae62089506c4fd6507227442b9f1249f6309019ca24a44e6a8e03a119b1eddc844096f554c371056606548bf48e809481376d1d2b54e70bcada54428bdd9197d2b19f7f31baed56267b6d89a45ae4eb84a57c1b98715a32e4cb2a127a956a96f16d15a89d7cb15d8f2b1149a5d536b151c858bae56c78786362a7bfd87551f5c6ccbe2557dfc6fe2603e5e11c8a862e230edd5933d50cdd22e939c1f2796d26f02a05c2e552ce2cdbb9d7995e6977dea6fb298222341700b89562f9d170bad5c2a9343a9ed4e87d4aa7c45a78390714b99b172abdb45353dd0b662d093f039ae9dd0c3764a0cedd05555e6bfaf1698c198e511ae1eca8ba79f283687203cfa542ea1b31a6e78ca289056048d806ab0af09e1625675111686599c2a9d58d002e725e6561286d1d69eb1acb3dcab4cc5d62cf81ef2a331293970e079150031e4321659186e874ebe27cb61c69ccdb0219c4d6634bfbb9f46e7f383c11161442a56c0adcc61f5a2ccaba423b67df28203e16056abde86d3cbed69ce07263404550dad0710e655ecfe51938205803b501bc815cb259c9249975299c7324086111828cb39dfe199090bca1300e14426aa3a85fa98a8146bc1ba5e5f9a1e56397f670fab5b982be3744fc65eb28d02d2d2218b162d09a7100e4307310b0e2630c85e950e2d8b0a0b730acfd95ecb994609f095bd345aa5f003dd4d7e9c9d63e2b5969479239ea8298869d5fcbe946899e1fd4d23cd950ca27db2cf588788131938c3aa66433c47d9ac9f71afea7d3cc930b73a072ef4f7e6bf0abd3c9ea9252e7c65f97700bf9f2bffc1eb6fbfff89e56c582f29c761d83fd287143f1fe9538af50dbf469f69dc3a311c613dc43f94eee7d6abd1694a3f4372d018d2e6a4c59a11ef63c6f0106b0c407437d96de5037e66e89574b410dcbcc242f6dcadc758d5a8eaf58befd50aea6c77c592ef20c7902f34eb7106b6d6027b2a17bb397422de125f37ffb693b52677030ded06b21418a9280c2f5f166c8f2e0514bb9db8470fab0e3d63e93b1d1cc3e30e7d1ce1ef0b3317a837be35e87d1ae3bd586065ae3cfe0b70b275c5',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155115,677,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155117,677,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155119,677,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155137,679,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155139,679,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155141,679,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155159,4234,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155161,4234,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155163,4234,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155181,4235,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155183,4235,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155185,4235,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'789cb556c972e33610fd953e5a55b2365bb3e4a658f60cabe4a52c3ba91c2112121183040d80b275cb35e77c437e6cbe24af416a21ed2476a672d14202afbb5fbf5ea6d7f3c997739a5c4d6932bd8caea2f9ddede42ebabea24956a85869ad72127942aed40b117b91d1d25852f9af32f6cae494890d2d24892453b9725e5a99d0624352f9545ac207453f91a97f5d9235a597ae4717788417db6b563058379c4a8c93148b9c61576a2d73c673da3cc12a0ee28129dd8107660d43c29396c2791a0ebefdf6c7704cc0654b6c9ab18476860113a901c94e22ae9595021e53a274c9508e9ee0368d03c46040d98ccc9204c5262be0e042cb7054e69e84032b2d8796a5dbf9331c03e364b075a3f79d7426521695b5ac7471a9c5c19d1e1d3929691add9e9f71e6e674717d4bf7f3f363bab1b21015b7c14ed4408876565df5dde9d11d12602502ce649ec0b6484aed3925622503196f0b43391af6c6b4a2a3213e0e2fb9906367125566e404c00b0df606e1f41eeee5b90e7943270c397a1be4f05f0125320569a9674a4d691d475f3b5e9bb2225f311f85950e59af20bcf142b7b8884dee5916c170b0b333bc7df566f2bae1656c2c8c16264f1c7b236a5f80d264b4df660e879b04f51b445429ae62089506c4fd6507227442b9f1249f6309019ca24a44e6a8e03a119b1eddc844096f554c371056606548bf48e809481376d1d2b54e70bcada54428bdd9197d2b19f7f31baed56267b6d89a45ae4eb84a57c1b98715a32e4cb2a127a956a96f16d15a89d7cb15d8f2b1149a5d536b151c858bae56c78786362a7bfd87551f5c6ccbe2557dfc6fe2603e5e11c8a862e230edd5933d50cdd22e939c1f2796d26f02a05c2e552ce2cdbb9d7995e6977dea6fb298222341700b89562f9d170bad5c2a9343a9ed4e87d4aa7c45a78390714b99b172abdb45353dd0b662d093f039ae9dd0c3764a0cedd05555e6bfaf1698c198e511ae1eca8ba79f283687203cfa542ea1b31a6e78ca289056048d806ab0af09e1625675111686599c2a9d58d002e725e6561286d1d69eb1acb3dcab4cc5d62cf81ef2a331293970e079150031e4321659186e874ebe27cb61c69ccdb0219c4d6634bfbb9f46e7f383c11161442a56c0adcc61f5a2ccaba423b67df28203e16056abde86d3cbed69ce07263404550dad0710e655ecfe51938205803b501bc815cb259c9249975299c7324086111828cb39dfe199090bca1300e14426aa3a85fa98a8146bc1ba5e5f9a1e56397f670fab5b982be3744fc65eb28d02d2d2218b162d09a7100e4307310b0e2630c85e950e2d8b0a0b730acfd95ecb994609f095bd345aa5f003dd4d7e9c9d63e2b5969479239ea8298869d5fcbe946899e1fd4d23cd950ca27db2cf588788131938c3aa66433c47d9ac9f71afea7d3cc930b73a072ef4f7e6bf0abd3c9ea9252e7c65f97700bf9f2bffc1eb6fbfff89e56c582f29c761d83fd287143f1fe9538af50dbf469f69dc3a311c613dc43f94eee7d6abd1694a3f4372d018d2e6a4c59a11ef63c6f0106b0c407437d96de5037e66e89574b410dcbcc242f6dcadc758d5a8eaf58befd50aea6c77c592ef20c7902f34eb7106b6d6027b2a17bb397422de125f37ffb693b52677030ded06b21418a9280c2f5f166c8f2e0514bb9db8470fab0e3d63e93b1d1cc3e30e7d1ce1ef0b3317a837be35e87d1ae3bd586065ae3cfe0b70b275c5',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (155203,4236,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155205,4236,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155207,4236,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155225,4240,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155227,4240,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155229,4240,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155247,4241,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155249,4241,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155251,4241,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'789cb556c972e33610fd953e5a55b2365bb3e4a658f60cabe4a52c3ba91c2112121183040d80b275cb35e77c437e6cbe24af416a21ed2476a672d14202afbb5fbf5ea6d7f3c997739a5c4d6932bd8caea2f9ddede42ebabea24956a85869ad72127942aed40b117b91d1d25852f9af32f6cae494890d2d24892453b9725e5a99d0624352f9545ac207453f91a97f5d9235a597ae4717788417db6b563058379c4a8c93148b9c61576a2d73c673da3cc12a0ee28129dd8107660d43c29396c2791a0ebefdf6c7704cc0654b6c9ab18476860113a901c94e22ae9595021e53a274c9508e9ee0368d03c46040d98ccc9204c5262be0e042cb7054e69e84032b2d8796a5dbf9331c03e364b075a3f79d7426521695b5ac7471a9c5c19d1e1d3929691add9e9f71e6e674717d4bf7f3f363bab1b21015b7c14ed4408876565df5dde9d11d12602502ce649ec0b6484aed3925622503196f0b43391af6c6b4a2a3213e0e2fb9906367125566e404c00b0df606e1f41eeee5b90e7943270c397a1be4f05f0125320569a9674a4d691d475f3b5e9bb2225f311f85950e59af20bcf142b7b8884dee5916c170b0b333bc7df566f2bae1656c2c8c16264f1c7b236a5f80d264b4df660e879b04f51b445429ae62089506c4fd6507227442b9f1249f6309019ca24a44e6a8e03a119b1eddc844096f554c371056606548bf48e809481376d1d2b54e70bcada54428bdd9197d2b19f7f31baed56267b6d89a45ae4eb84a57c1b98715a32e4cb2a127a956a96f16d15a89d7cb15d8f2b1149a5d536b151c858bae56c78786362a7bfd87551f5c6ccbe2557dfc6fe2603e5e11c8a862e230edd5933d50cdd22e939c1f2796d26f02a05c2e552ce2cdbb9d7995e6977dea6fb298222341700b89562f9d170bad5c2a9343a9ed4e87d4aa7c45a78390714b99b172abdb45353dd0b662d093f039ae9dd0c3764a0cedd05555e6bfaf1698c198e511ae1eca8ba79f283687203cfa542ea1b31a6e78ca289056048d806ab0af09e1625675111686599c2a9d58d002e725e6561286d1d69eb1acb3dcab4cc5d62cf81ef2a331293970e079150031e4321659186e874ebe27cb61c69ccdb0219c4d6634bfbb9f46e7f383c11161442a56c0adcc61f5a2ccaba423b67df28203e16056abde86d3cbed69ce07263404550dad0710e655ecfe51938205803b501bc815cb259c9249975299c7324086111828cb39dfe199090bca1300e14426aa3a85fa98a8146bc1ba5e5f9a1e56397f670fab5b982be3744fc65eb28d02d2d2218b162d09a7100e4307310b0e2630c85e950e2d8b0a0b730acfd95ecb994609f095bd345aa5f003dd4d7e9c9d63e2b5969479239ea8298869d5fcbe946899e1fd4d23cd950ca27db2cf588788131938c3aa66433c47d9ac9f71afea7d3cc930b73a072ef4f7e6bf0abd3c9ea9252e7c65f97700bf9f2bffc1eb6fbfff89e56c582f29c761d83fd287143f1fe9538af50dbf469f69dc3a311c613dc43f94eee7d6abd1694a3f4372d018d2e6a4c59a11ef63c6f0106b0c407437d96de5037e66e89574b410dcbcc242f6dcadc758d5a8eaf58befd50aea6c77c592ef20c7902f34eb7106b6d6027b2a17bb397422de125f37ffb693b52677030ded06b21418a9280c2f5f166c8f2e0514bb9db8470fab0e3d63e93b1d1cc3e30e7d1ce1ef0b3317a837be35e87d1ae3bd586065ae3cfe0b70b275c5','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155269,10968,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155271,10968,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155273,10968,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155291,10969,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155293,10969,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155295,10969,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155313,10970,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155315,10970,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155317,10970,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155335,11888,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155337,11888,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155339,11888,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155357,11891,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155359,11891,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155361,11891,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155379,11896,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'789ccd595d52234712be4abe4c048a603480191bcf3e31806789180b0289d8e75277a955a6bbaba7aa5a8cde7c073fed2df60c7b149f64bfccaa6eb584d801af23d62f044855f9f3e5977fc5e5cdf4fcd3159d4f2ee9fcf2e7ebc9f57476773ebbbe99d06c693c99da6b1708bf2dac2345b74be52a95ade9635b3ed0adca1e54a149d539c9e1a0eb5ce772b671ba51ced4057fecd44ad7b6f5a4f2ca7c0dadd39e6c5daec774693d4b703ab35585db2a185b476d72af6a7dd696ca113ec80d8e852d79a6fe051fe10a29a7d32dfcac448c2aa9695d637dafedba5ec4e3f8604161c98a7d639c0ad6ad0962219e9df176112818ef5bedc77033185d074f8fda144b76e9f4881e0a3a383ba372ee476c5b659dfe4027ef8fa82a28587a7f24bfe99586e0ef69695bb75752a9bd8721aade91c9b2a21c8879f750bccbd51abe91fed2aab25c038b9561a873f14e05fafe2d1f3f7b2baa24146ea54abfcfe742f9e02c1ff1c1304aec72a16b1370151f7450783a307556b6391b1a96d044996a3db4ced734d180473ba3a8b0b5756e69b5d26ce142570a5e8d5e83dbff8ed69f819380139c56014c0c8c56b674b636196dc112e9be41cff4001fd2c241315f9ee320d0b1a52d4c9620ce4a53c73f9ac629e3f9aea75a67f00ad2c7340572a576c958f133c2dea7073c5173bbd2e4617e99536da14a1307654c7f074afded74207d29a9e1433b9f5b5733ee9eb1d603db0580fec4d027a0e254b3a60ac8ced9962f2d1231896431f0e351eb071611ba53bd578c76666b40d5ea010275fe0ed777515ad8b2b48f6fdb664b7885eb4b046f81b3246225e3239bd9b431dd3b1d96ce04a9422404a41c0aa17c321e32744ce7795b8253bffffa1bcd1e6d420bb23a0eaa6cc93c51754f0efef68c451d9f74d49cf52ce95169f00950318b81ef70427f4d45115f74d03d43365b352560e8733599ad6141dbfb7748be650b3d2aacf501a7d969a6976e4c6ef275154fe1dbd2d6051326d1b5f606c4e9a2894b03568de942251c7aadf4680214419f6f4006486a9ca9d82da09b02e0d7cdd294a6a7db12859972e51e1646e34ffd5555c891e8d15c23a8c2658da4e492d2792f7880fa64d93a141936e571c904057560a4090a18f5ca585f67d461a407521dd5a8271227e730072a95ebd4c26090a9da8aad5f700988ec4248118f48063ec7d169d8d43cb6b0be86a67817c0b2e63aa88dd8cce79f34ac61a772b60dcc3ed41485b0309d2c935b558dc94c590a6dd7bdadf0be963a6101bae29b1f63aee0cacf28d57521714f6496ea026c72875bccec63d4436838397a51598c75f73bbe71da31fce009c5815b30c27121c6d0b9dc99a667961893327e78b647a66fda7e3cda813d12e0157027039e8c0b09ee89c6180032d0c1a6757052320c02d019d8ba16de634e0838cb2129f448504cc3c9864673c5b514d4ffa425f564c6e826a0dba1005259665dec9c96666a5e6a3aa671f7db874e3662f2c76d64c4f6d282cd99ea26984c57e8d0bbd61e48b91eed587cc05a469d61fb6df9eef4992f7ea0e3d770adaba4cfab29987e12697cb7fbf7f0ec9978bb9103b88e5f360dec98b2abf1d968bc4afc59923e08c76b921643415098c09fa41c4fd2b5c120179ba1d4b6009b31dbc168a77524cd3019a390a7954a72656f11f88ba5cf81cc3ea361fb85666e1c838ab151b729424f2affa9f4f31fbad0cff5dac20469c9a6e226a9426c017104c50174211e20fdba6a82e5fd22132438e075a659e6bccf44d4c13c35727444168f08db7950a6e6567b3eb4e4f82842b81905b63b73b4bd5e6f5c1c0ce19f10ba06f2e63aa8b74b5dd972cd868115609bcd6c9619f673a9cb86bbd98ac5b35bf8a275ae335c651c7fb4fc36fab5602ab077f18ba284ebaec534a19b3883606dbbbebbba9035f1a79b3bba9f5ed14f387fbecd4918783d602c169156e606e6c61d3cac314007d60088e26ec75e694c8074e041e04bf9acdf076fd10b61d7bd17a3f76fa2239e51b87d63b033651b9840718ca9b7b2c75bfed2d6983c7ebebdb99b9d4f661fe2c69b01461921c0d039a68db01eae949cedb5a547c97b89711cd41135e468473c9017f80b691bde1890f76c11a286b34626b7bcc522f1a841dd38d6a679032b73d4c3341cd3276b79eab20b645f5a683b79be2d0a1972443bcf8eb68dfbc166c5dea442572d340fee8afde79559340fb52a99ad16282206c64bed49186033c88decd1c389c5dbdc80c630a09bd5795ed37562800ce32b8588c8aafe147edfa32800e4aee570019492b79e4dcd393e7a43ecf78a4d49a91974053aa8e829f6a0942a7d0e37bc58e49ee31838ebeeacad68b6b9440727effffd2fba40c7035338332eb66ddf387f9b444d39bf11d47f489f606dd7fdfbc3fdf496908bdcbca47c579ffbd27f34fef10d4d235417cbd23ad48c97dd7cff862eb140384663fbc2716a15e9c2715c679f3f1f159ca4e3277be4730d3e1a9fe2a389ba285f74fd33622203e11df24cbbdf7ffda77f995f777ae14cc181c0e583d33f390cbdbad3bef9be28703d9a7d5f7841e47a6527a7af0df7c9133b5f0d68aff49b91ff2f4c7941e48f77aedfd41877e2dbc426974b2e303b0f14c3f787dda1dd740d817bd0a6a8c457bc64c3211b1197b39dd292142cb8fd73893771a576b25df17268b083e669afe3c2b2755f9c8ee7434460053f2addbd91f5b60d6be82fad38e8ed6640089627161ef876bc307ebbe8a6edb72f73a5cc8826f8ad4623df7788f2df006ffc471aa1f4b2fd5f15a5425d9ddb10ca3823612cf17baa3a3f56ac5429338330a0c0cce8b7dd94271f68cab537459de2cc7d2eb9d27416e0ef6fbe0803707c8919912765d4f76c599b2fadc85254ca4b029297c78325fae298d40813474e3f9e1288f98d148f3c80168cdeaca5c758da4d4221ee30ec5874758049df7d18f9eaf361f7e6ed639b8f597233b98ae90172386e37831e35a6792c71a0dba275b2c526daf6d72042edd0941fa6d293b2e460d28fd68c0129cec5f254d69a68c8a26c0da0616e606ec0accacfdeffcfc1e6af37d46423c0b39f69accced239bbc825286a4e5c9616342a36b1d621be3ff30e0479a3ea2196e33e5b22589e09b68f944dadca060d5f2add7e16ff4b834fcc6c78fa19e2a58deb28b8353a94a316ff9857cdc1503c85e738ac592566b9d43ba91f968fb11994b8f3caec832c17b23d78631e5c829319d29b83e94d0e257e336ca64d789d56348b1bde7d8c8fd5508dba73c5d27a7d24bd1301bec6207bf4464c1b734151ce80351987a7bbb151e768f94b694cd47fe8514670c1cb1cf1bd7c3b9456ad9cbb0dc18d9532457fb403e5af7c0ff82529be7d9bd25eb1667f855997b067781247bc86a14e3f4dcba323ebe2bc8ffd3940357b1af077e210c1c220e31e0cb2c668c48f57ef9d97e1d3894e744d9eafabad73d0cf04eeab8aa00cf315d9cdff356f7812637339addd0c72bac7ad3dbabc9f4ea92cea75835ef27d7b3f17f003c3d1b66','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (155381,11896,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'789ccd564b72dc3610bd4a2f67aaa4b17eb6a7b253a294a285655734ce1e247b4844244003e0c8dce50eb9470e91a3e424790d901c6a2455594916d971068deed7af5f77e3eae3dde5f58f74797b4597571f6e6e6fee363f5f6e6e3eded2a662bad3a6ac993e7bc6e9d5f12fca0455f29f7fd04eabda93724c5beb489be0d48e8ded3c75b0b5a6ee577463b69c076d8d27bba500778e7dab9d0ad6f5841b7920650af2761b2868ef3bf62bfaa48266133c3db02e2bc4a78b13ba2f69b15e539df925215e631d7f47676f4fa82929587a7b12bf78c770fc8e2adbb9673dd5ec3d802873e0537c253f70f3e6be7c53a81e49117fe9545df754e89d2eb8a0c27a46d681de1d8bf9fa388692f4d9ed40c8733997ca0767c5c4076d541d532ed9e880abf863a4c2d3429bbcee0a011a2a44a25c81cc82b29e6e19f4b0d38a4a6bac739565c58270cb8d4256cbd7f0f6efd9fa2f788ae404c72a34082b6ce595b346e7f4889648d78c3d3d117c445b87c072398321d8b1b52d753e509cd7daa41f6deb94f672d793e11c59c1fb8aeec05ccd6e001bf34cb43bce6d03509289caec8ec9037e5d90b108c5a2f062453f81a5e9f660301cc69ef0a1cb32eb8cf0ee856b9e618f044c16f39cc08a536d4f0d98cd04cb974ebbd1a5b8411e0fccf7e2228c565356c2766e0da8ea78c68029dee0fa214b5b5bd7f6e1b86b1f396f70bd42f1b6b0a5e856900d6a16682bfaec38544ea365a5f8518054202082dfaee60a5dd165d1d5d0d45fbffd4e9b073bb0055fa306555e894e9499c421a76b71757a364a7333a96462a5c53f60456f67b92309fe1a52dd703052f782d86cd3d6a061ead50136034137e57744be13849e5a677d80b5242df2e25617bae89b6485d3da9a520433c8d5780de18cd5c4a599aa56f4831a7898a2d2830e088478be8518e0a975ba91b4c0ee5000dfb795aef524b70a33970ae5eeb79af193bfaa063d9232ca18458d5a6634a58c9431fbc807a44f56d061c80894874a040ae900a40e18f3fb60126f047594e48156c7349a8424cd39ef814615692f280220dd748da0dfca0848ea5ac5e592c42076529d56a0c6e1b76f87b1de25b83432075947cc621f774ed3f9bcab95a38325e46c17447d98290a6511395911b76a5a9debba8eb2ed27acc8dec4396141ba929bdfa75ec1950f18d5a68c751fc41ca70bb8291c6e89b24f310f11e1ece49bc6629abbe772e36254f8e289c4c15bd051e35118f3e40aa7db495911ccd0f173db89196d7e1d87cef280f6248057d03d0018c99e620c74dfb285fce07cb15f1dd294424324680db5f651f72dba09b652929297744c57d6e36b26a24cc92485f0af39369e35c93866fc697e9d549e5b97f6a6a58dcaf06239a7d5f435b84641fe3940a1eb594d089a3b6e83ceb9c17a3e04bb88b37a79007821519623b0e7b19c5fbc70f09e4e5f23b4718cbe1ca614edc5321f9cad6376fb7ba0e7f4db56ff41e847115e4cecb5eed783f719fdafe950bc008272e1697fa942a6165e6d69f3c5411680190f398076cc4924f3ce4b4e9e8ea5d818cf76fcffaa5716f199b39c6f5ac4951d311b0efb70fb79f364c85fc4d5fd7e2c7cc6bd0584b87d7523fb508534edd36b13065838f256f47dd306dbe0ef3cf220e536398bcf6cea3b8cbc62d8d9587ee21ef5b55950dac856bd9c23393d4904eeb7fee3259cb09b7e9fe2ecbd7d8dc2b5f0977150c71537b6ee05183401add9dce6b9963c2bae5b595c3b712f69e1a0736e04ae72a93eb67b97f2da8a1024bb7450d648dd757838709b9e1babbf01c61cd8fc','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155383,11896,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155401,11898,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155403,11898,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155405,11898,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'789cb556c972e33610fd953e5a55b2365bb3e4a658f60cabe4a52c3ba91c2112121183040d80b275cb35e77c437e6cbe24af416a21ed2476a672d14202afbb5fbf5ea6d7f3c997739a5c4d6932bd8caea2f9ddede42ebabea24956a85869ad72127942aed40b117b91d1d25852f9af32f6cae494890d2d24892453b9725e5a99d0624352f9545ac207453f91a97f5d9235a597ae4717788417db6b563058379c4a8c93148b9c61576a2d73c673da3cc12a0ee28129dd8107660d43c29396c2791a0ebefdf6c7704cc0654b6c9ab18476860113a901c94e22ae9595021e53a274c9508e9ee0368d03c46040d98ccc9204c5262be0e042cb7054e69e84032b2d8796a5dbf9331c03e364b075a3f79d7426521695b5ac7471a9c5c19d1e1d3929691add9e9f71e6e674717d4bf7f3f363bab1b21015b7c14ed4408876565df5dde9d11d12602502ce649ec0b6484aed3925622503196f0b43391af6c6b4a2a3213e0e2fb9906367125566e404c00b0df606e1f41eeee5b90e7943270c397a1be4f05f0125320569a9674a4d691d475f3b5e9bb2225f311f85950e59af20bcf142b7b8884dee5916c170b0b333bc7df566f2bae1656c2c8c16264f1c7b236a5f80d264b4df660e879b04f51b445429ae62089506c4fd6507227442b9f1249f6309019ca24a44e6a8e03a119b1eddc844096f554c371056606548bf48e809481376d1d2b54e70bcada54428bdd9197d2b19f7f31baed56267b6d89a45ae4eb84a57c1b98715a32e4cb2a127a956a96f16d15a89d7cb15d8f2b1149a5d536b151c858bae56c78786362a7bfd87551f5c6ccbe2557dfc6fe2603e5e11c8a862e230edd5933d50cdd22e939c1f2796d26f02a05c2e552ce2cdbb9d7995e6977dea6fb298222341700b89562f9d170bad5c2a9343a9ed4e87d4aa7c45a78390714b99b172abdb45353dd0b662d093f039ae9dd0c3764a0cedd05555e6bfaf1698c198e511ae1eca8ba79f283687203cfa542ea1b31a6e78ca289056048d806ab0af09e1625675111686599c2a9d58d002e725e6561286d1d69eb1acb3dcab4cc5d62cf81ef2a331293970e079150031e4321659186e874ebe27cb61c69ccdb0219c4d6634bfbb9f46e7f383c11161442a56c0adcc61f5a2ccaba423b67df28203e16056abde86d3cbed69ce07263404550dad0710e655ecfe51938205803b501bc815cb259c9249975299c7324086111828cb39dfe199090bca1300e14426aa3a85fa98a8146bc1ba5e5f9a1e56397f670fab5b982be3744fc65eb28d02d2d2218b162d09a7100e4307310b0e2630c85e950e2d8b0a0b730acfd95ecb994609f095bd345aa5f003dd4d7e9c9d63e2b5969479239ea8298869d5fcbe946899e1fd4d23cd950ca27db2cf588788131938c3aa66433c47d9ac9f71afea7d3cc930b73a072ef4f7e6bf0abd3c9ea9252e7c65f97700bf9f2bffc1eb6fbfff89e56c582f29c761d83fd287143f1fe9538af50dbf469f69dc3a311c613dc43f94eee7d6abd1694a3f4372d018d2e6a4c59a11ef63c6f0106b0c407437d96de5037e66e89574b410dcbcc242f6dcadc758d5a8eaf58befd50aea6c77c592ef20c7902f34eb7106b6d6027b2a17bb397422de125f37ffb693b52677030ded06b21418a9280c2f5f166c8f2e0514bb9db8470fab0e3d63e93b1d1cc3e30e7d1ce1ef0b3317a837be35e87d1ae3bd586065ae3cfe0b70b275c5',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155423,11901,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155425,11901,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155427,11901,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155445,14030,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155447,14030,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155449,14030,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155467,14031,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155469,14031,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155471,14031,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155489,14033,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155491,14033,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155493,14033,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155511,14035,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155513,14035,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155515,14035,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155533,14036,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155535,14036,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155537,14036,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(155555,14038,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(155557,14038,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL);
